US Stock MarketDetailed Quotes

Immix Biopharma (IMMX)

Watchlist
  • 4.700
  • -0.010-0.21%
Close Jan 16 16:00 ET
  • 4.660
  • -0.040-0.85%
Post 19:39 ET
248.89MMarket Cap-6.10P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Immix Biopharma (IMMX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
3.62%7.66M
42.85%6.72M
-16.23%4.68M
40.48%22.67M
-7.23%4.99M
63.47%7.39M
26.39%4.7M
121.76%5.59M
96.39%16.14M
41.67%5.38M
Selling and administrative expenses
4.37%3.08M
10.77%2.75M
15.65%2.71M
53.68%11.38M
58.80%3.61M
21.99%2.95M
63.97%2.48M
94.84%2.34M
84.09%7.41M
48.50%2.28M
-General and administrative expense
4.37%3.08M
10.77%2.75M
15.65%2.71M
53.68%11.38M
58.80%3.61M
21.99%2.95M
63.97%2.48M
94.84%2.34M
84.09%7.41M
48.50%2.28M
Research and development costs
3.12%4.58M
78.61%3.97M
-39.20%1.98M
29.28%11.29M
-55.68%1.37M
111.09%4.45M
0.67%2.22M
146.29%3.25M
108.19%8.74M
37.05%3.1M
Operating profit
-3.62%-7.66M
-42.85%-6.72M
16.23%-4.68M
-40.48%-22.67M
7.23%-4.99M
-63.47%-7.39M
-26.39%-4.7M
-121.76%-5.59M
-96.39%-16.14M
-41.67%-5.38M
Net non-operating interest income expense
-67.06%84.54K
-66.10%104.06K
-43.93%150.22K
77.86%1.02M
-18.69%185.85K
37.49%256.68K
138.20%306.92K
860.52%267.91K
115,191.75%572.01K
228.58K
Non-operating interest income
-67.06%84.54K
-66.10%104.06K
-43.93%150.22K
77.86%1.02M
-18.69%185.85K
37.49%256.68K
138.20%306.92K
860.52%267.91K
--572.01K
--228.58K
Other net income (expense)
Income before tax
-6.16%-7.58M
-50.46%-6.61M
14.83%-4.53M
-39.10%-21.66M
6.72%-4.8M
-64.59%-7.14M
-22.38%-4.4M
-113.50%-5.32M
-89.42%-15.57M
-35.65%-5.15M
Income tax
-30.71%7.72K
-13.20%8.91K
11.12%9.82K
55.35%41.04K
33.33%10.79K
63.71%11.14K
61.74%10.27K
70.97%8.84K
157.26%26.42K
53.81%8.09K
Net income
-6.10%-7.59M
-50.31%-6.62M
14.79%-4.54M
-39.13%-21.7M
6.66%-4.81M
-64.58%-7.15M
-22.45%-4.41M
-113.41%-5.33M
-89.50%-15.6M
-35.67%-5.16M
Net income continuous Operations
-6.10%-7.59M
-50.31%-6.62M
14.79%-4.54M
-39.13%-21.7M
6.66%-4.81M
-64.58%-7.15M
-22.45%-4.41M
-113.41%-5.33M
-89.50%-15.6M
-35.67%-5.16M
Minority interest income
0
0
0
49.85%-84.99K
0
0
41.29%-12.91K
-292.38%-72.07K
-169.47K
-65.86K
Net income attributable to the parent company
-6.10%-7.59M
-50.75%-6.62M
13.62%-4.54M
-40.11%-21.61M
5.45%-4.81M
-67.02%-7.15M
-22.84%-4.39M
-112.08%-5.26M
-87.44%-15.43M
-33.94%-5.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-6.10%-7.59M
-50.75%-6.62M
13.62%-4.54M
-40.11%-21.61M
5.45%-4.81M
-67.02%-7.15M
-22.84%-4.39M
-112.08%-5.26M
-87.44%-15.43M
-33.94%-5.09M
Basic earnings per share
0.00%-0.24
-46.67%-0.22
31.82%-0.15
14.61%-0.76
33.33%-0.16
-4.35%-0.24
37.50%-0.15
-22.22%-0.22
-50.85%-0.89
11.11%-0.24
Diluted earnings per share
0.00%-0.24
-46.67%-0.22
31.82%-0.15
14.61%-0.76
33.33%-0.16
-4.35%-0.24
37.50%-0.15
-22.22%-0.22
-50.85%-0.89
11.11%-0.24
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 3.62%7.66M42.85%6.72M-16.23%4.68M40.48%22.67M-7.23%4.99M63.47%7.39M26.39%4.7M121.76%5.59M96.39%16.14M41.67%5.38M
Selling and administrative expenses 4.37%3.08M10.77%2.75M15.65%2.71M53.68%11.38M58.80%3.61M21.99%2.95M63.97%2.48M94.84%2.34M84.09%7.41M48.50%2.28M
-General and administrative expense 4.37%3.08M10.77%2.75M15.65%2.71M53.68%11.38M58.80%3.61M21.99%2.95M63.97%2.48M94.84%2.34M84.09%7.41M48.50%2.28M
Research and development costs 3.12%4.58M78.61%3.97M-39.20%1.98M29.28%11.29M-55.68%1.37M111.09%4.45M0.67%2.22M146.29%3.25M108.19%8.74M37.05%3.1M
Operating profit -3.62%-7.66M-42.85%-6.72M16.23%-4.68M-40.48%-22.67M7.23%-4.99M-63.47%-7.39M-26.39%-4.7M-121.76%-5.59M-96.39%-16.14M-41.67%-5.38M
Net non-operating interest income expense -67.06%84.54K-66.10%104.06K-43.93%150.22K77.86%1.02M-18.69%185.85K37.49%256.68K138.20%306.92K860.52%267.91K115,191.75%572.01K228.58K
Non-operating interest income -67.06%84.54K-66.10%104.06K-43.93%150.22K77.86%1.02M-18.69%185.85K37.49%256.68K138.20%306.92K860.52%267.91K--572.01K--228.58K
Other net income (expense)
Income before tax -6.16%-7.58M-50.46%-6.61M14.83%-4.53M-39.10%-21.66M6.72%-4.8M-64.59%-7.14M-22.38%-4.4M-113.50%-5.32M-89.42%-15.57M-35.65%-5.15M
Income tax -30.71%7.72K-13.20%8.91K11.12%9.82K55.35%41.04K33.33%10.79K63.71%11.14K61.74%10.27K70.97%8.84K157.26%26.42K53.81%8.09K
Net income -6.10%-7.59M-50.31%-6.62M14.79%-4.54M-39.13%-21.7M6.66%-4.81M-64.58%-7.15M-22.45%-4.41M-113.41%-5.33M-89.50%-15.6M-35.67%-5.16M
Net income continuous Operations -6.10%-7.59M-50.31%-6.62M14.79%-4.54M-39.13%-21.7M6.66%-4.81M-64.58%-7.15M-22.45%-4.41M-113.41%-5.33M-89.50%-15.6M-35.67%-5.16M
Minority interest income 00049.85%-84.99K0041.29%-12.91K-292.38%-72.07K-169.47K-65.86K
Net income attributable to the parent company -6.10%-7.59M-50.75%-6.62M13.62%-4.54M-40.11%-21.61M5.45%-4.81M-67.02%-7.15M-22.84%-4.39M-112.08%-5.26M-87.44%-15.43M-33.94%-5.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -6.10%-7.59M-50.75%-6.62M13.62%-4.54M-40.11%-21.61M5.45%-4.81M-67.02%-7.15M-22.84%-4.39M-112.08%-5.26M-87.44%-15.43M-33.94%-5.09M
Basic earnings per share 0.00%-0.24-46.67%-0.2231.82%-0.1514.61%-0.7633.33%-0.16-4.35%-0.2437.50%-0.15-22.22%-0.22-50.85%-0.8911.11%-0.24
Diluted earnings per share 0.00%-0.24-46.67%-0.2231.82%-0.1514.61%-0.7633.33%-0.16-4.35%-0.2437.50%-0.15-22.22%-0.22-50.85%-0.8911.11%-0.24
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.35%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.57%
4
Kingsoft Cloud
KC
+7.99%
5
United Microelectronics
UMC
+5.80%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -